0001127602-17-010543.txt : 20170307 0001127602-17-010543.hdr.sgml : 20170307 20170307153313 ACCESSION NUMBER: 0001127602-17-010543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170306 FILED AS OF DATE: 20170307 DATE AS OF CHANGE: 20170307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edge Therapeutics, Inc. CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOUGHLIN JAMES J CENTRAL INDEX KEY: 0001276550 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 17671780 MAIL ADDRESS: STREET 1: DORSEY & WHITNEY LLP STREET 2: 250 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10177 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-03-06 0001472091 Edge Therapeutics, Inc. EDGE 0001276550 LOUGHLIN JAMES J 300 CONNELL DRIVE, SUITE 4000 BERKELEY HEIGHTS NJ 07922 1 Common Stock 2017-03-06 4 P 0 3000 9.24 A 6000 I Family Trust Common Stock 19625 D The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ James J. Loughlin by Albert N. Marchio II, attorney-in-fact 2017-03-07